Hartland & Co. LLC lowered its stake in Colgate-Palmolive Company (NYSE:CL) by 3.9% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 20,968 shares of the company’s stock after selling 845 shares during the period. Hartland & Co. LLC’s holdings in Colgate-Palmolive were worth $1,535,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in CL. AlphaMark Advisors LLC increased its position in shares of Colgate-Palmolive by 452.1% in the 1st quarter. AlphaMark Advisors LLC now owns 1,673 shares of the company’s stock worth $122,000 after purchasing an additional 1,370 shares during the last quarter. North Star Investment Management Corp. increased its position in shares of Colgate-Palmolive by 3.9% in the 1st quarter. North Star Investment Management Corp. now owns 1,797 shares of the company’s stock worth $132,000 after purchasing an additional 67 shares during the last quarter. Blue Chip Partners Inc. increased its position in shares of Colgate-Palmolive by 0.4% in the 1st quarter. Blue Chip Partners Inc. now owns 1,805 shares of the company’s stock worth $132,000 after purchasing an additional 8 shares during the last quarter. Advantage Investment Management LLC increased its position in shares of Colgate-Palmolive by 16.8% in the 1st quarter. Advantage Investment Management LLC now owns 1,850 shares of the company’s stock worth $135,000 after purchasing an additional 266 shares during the last quarter. Finally, Heritage Trust Co bought a new stake in shares of Colgate-Palmolive in the 1st quarter worth about $146,000. 73.16% of the stock is owned by institutional investors.
CL has been the subject of several research reports. Zacks Investment Research raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $83.00 price target for the company in a report on Tuesday, July 4th. Bank of America Corporation lifted their price target on shares of Colgate-Palmolive from $78.00 to $80.00 and gave the company a “buy” rating in a report on Wednesday, May 31st. Jefferies Group LLC reaffirmed a “hold” rating and issued a $79.00 price target on shares of Colgate-Palmolive in a report on Thursday, August 24th. Royal Bank Of Canada reaffirmed a “hold” rating and issued a $74.00 price target on shares of Colgate-Palmolive in a report on Thursday, May 25th. Finally, Deutsche Bank AG reaffirmed a “hold” rating and issued a $75.00 price target on shares of Colgate-Palmolive in a report on Monday, July 24th. Two analysts have rated the stock with a sell rating, thirteen have given a hold rating and two have issued a buy rating to the company. Colgate-Palmolive presently has an average rating of “Hold” and a consensus price target of $75.83.
In related news, insider Patricia Verduin sold 3,833 shares of the firm’s stock in a transaction on Monday, July 17th. The shares were sold at an average price of $72.41, for a total value of $277,547.53. Following the completion of the transaction, the insider now directly owns 53,022 shares of the company’s stock, valued at $3,839,323.02. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, COO Justin Skala sold 74,374 shares of the firm’s stock in a transaction on Thursday, July 27th. The shares were sold at an average price of $72.51, for a total transaction of $5,392,858.74. Following the completion of the transaction, the chief operating officer now directly owns 97,177 shares of the company’s stock, valued at $7,046,304.27. The disclosure for this sale can be found here. Insiders sold 217,969 shares of company stock worth $15,693,933 over the last quarter. 1.02% of the stock is owned by corporate insiders.
Shares of Colgate-Palmolive Company (NYSE CL) traded down 0.090% during mid-day trading on Friday, hitting $72.075. 1,990,916 shares of the stock were exchanged. Colgate-Palmolive Company has a 1-year low of $63.43 and a 1-year high of $77.27. The company’s 50-day moving average is $71.59 and its 200-day moving average is $73.29. The firm has a market cap of $63.49 billion, a price-to-earnings ratio of 26.784 and a beta of 0.80.
Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, July 21st. The company reported $0.72 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $0.72. Colgate-Palmolive had a net margin of 15.83% and a return on equity of 3,121.95%. The company had revenue of $3.83 billion for the quarter, compared to the consensus estimate of $3.89 billion. During the same period last year, the company earned $0.70 earnings per share. The firm’s revenue was down .5% compared to the same quarter last year. Equities research analysts anticipate that Colgate-Palmolive Company will post $2.89 earnings per share for the current fiscal year.
ILLEGAL ACTIVITY WARNING: “Colgate-Palmolive Company (NYSE:CL) Shares Sold by Hartland & Co. LLC” was first posted by BBNS and is owned by of BBNS. If you are reading this story on another publication, it was copied illegally and reposted in violation of international trademark & copyright law. The legal version of this story can be accessed at https://baseballnewssource.com/markets/hartland-co-llc-sells-845-shares-of-colgate-palmolive-company-cl/1604535.html.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with our FREE daily email newsletter.